Clinical Trials Research

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease2 trials
• Diabetic neuropathy2 trials
• Fatty liver disease (MASLD/MASH)1 trial
• Obesity1 trial
• Type 2 diabetes1 trial

Phase

• Phase 35 trials
• Phase 21 trial

Status

• Active, not recruiting3 trials
• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Pfizer2 trials
• Vertex Pharmaceuticals Incorporated2 trials

Running trials

• Recruiting

  A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  NCT07595549· Phase 3· Pfizer· Source

• Active, not recruiting

  Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)

  NCT06696443· Phase 3· Vertex Pharmaceuticals Incorporated· Source

• Active, not recruiting

  A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

  NCT06653153· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

  NCT06628908· Phase 3· Vertex Pharmaceuticals Incorporated· Source

• Active, not recruiting

  A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

  NCT05026866· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Diabetic neuropathy1 recruiting
• Obesity1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

  NCT04321031· Phase 2· Pfizer· Source